<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Cell Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Cell. Biol</journal-id>
<journal-id journal-id-type="hwp">mcb</journal-id>
<journal-id journal-id-type="pmc">mcb</journal-id>
<journal-id journal-id-type="publisher-id">MCB</journal-id>
<journal-title-group>
<journal-title>Molecular and Cellular Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-7306</issn>
<issn pub-type="epub">1098-5549</issn>
<publisher>
<publisher-name>American Society for Microbiology</publisher-name>
<publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31383751</article-id>
<article-id pub-id-type="pmc">6791656</article-id>
<article-id pub-id-type="publisher-id">00155-19</article-id>
<article-id pub-id-type="doi">10.1128/MCB.00155-19</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Correction of Glycogen Synthase Kinase 3β in Myotonic Dystrophy 1 Reduces the Mutant RNA and Improves Postnatal Survival of DMSXL Mice</article-title>
<alt-title alt-title-type="running-head">GSK3β in DM1</alt-title>
<alt-title alt-title-type="short-authors">Wang et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Mei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Weng</surname>
<given-names>Wen-Chin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stock</surname>
<given-names>Lauren</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lindquist</surname>
<given-names>Diana</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martinez</surname>
<given-names>Ana</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gourdon</surname>
<given-names>Genevieve</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Timchenko</surname>
<given-names>Nikolai</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Snape</surname>
<given-names>Mike</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Timchenko</surname>
<given-names>Lubov</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<aff id="aff1">
<label>a</label>
<addr-line>Division of Neurology, Cincinnati Children’s Hospital, Cincinnati, Ohio, USA</addr-line>
</aff>
<aff id="aff2">
<label>b</label>
<addr-line>Imaging Research Center, Cincinnati Children’s Hospital, Cincinnati, Ohio, USA</addr-line>
</aff>
<aff id="aff3">
<label>c</label>
<addr-line>Centro de Investigaciones Biológicas (CIB, CSIC), Madrid, Spain</addr-line>
</aff>
<aff id="aff4">
<label>d</label>
<addr-line>Inserm UMR1163, Institut Imagine, Université Paris Descartes-Sorbonne Paris Cité, Paris, France</addr-line>
</aff>
<aff id="aff5">
<label>e</label>
<addr-line>Departments of Surgery, Cincinnati Children’s Hospital, University of Cincinnati, College of Medicine, Cincinnati, Ohio, USA</addr-line>
</aff>
<aff id="aff6">
<label>f</label>
<addr-line>Departments of Pediatrics, University of Cincinnati, College of Medicine, Cincinnati, Ohio, USA</addr-line>
</aff>
<aff id="aff7">
<label>g</label>
<addr-line>AMO Pharma Ltd., Wonersh, Surrey, United Kingdom</addr-line>
</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Address correspondence to Lubov Timchenko, <email>Lubov.Timchenko@cchmc.org</email>.</corresp>
<fn fn-type="present-address" id="fn1">
<label>*</label>
<p>Present address: Wen-Chin Weng, Division of Pediatric Neurology, National Taiwan University College of Medicine, Taipei, Taiwan.</p>
</fn>
<fn fn-type="other">
<p><bold>Citation</bold> Wang M, Weng W-C, Stock L, Lindquist D, Martinez A, Gourdon G, Timchenko N, Snape M, Timchenko L. 2019. Correction of glycogen synthase kinase 3β in myotonic dystrophy 1 reduces the mutant RNA and improves postnatal survival of DMSXL mice. Mol Cell Biol 39:e00155-19. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/MCB.00155-19">https://doi.org/10.1128/MCB.00155-19</ext-link>.</p>
</fn>
</author-notes>
<pub-date pub-type="epreprint">
<day>5</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>11</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<day>1</day>
<month>11</month>
<year>2019</year>
</pub-date>
<volume>39</volume>
<issue>21</issue>
<elocation-id>e00155-19</elocation-id>
<history>
<date date-type="received">
<day>9</day>
<month>4</month>
<year>2019</year>
</date>
<date date-type="rev-request">
<day>2</day>
<month>5</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>1</day>
<month>8</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 American Society for Microbiology.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>American Society for Microbiology</copyright-holder>
<license license-type="asm" xlink:href="https://doi.org/10.1128/ASMCopyrightv2">
<license-p><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/ASMCopyrightv2">All Rights Reserved</ext-link>.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="MCB.00155-19.pdf"></self-uri>
<abstract abstract-type="precis">
<p>Myotonic dystrophy type 1 (DM1) is a multisystem neuromuscular disease without cure. One of the possible therapeutic approaches for DM1 is correction of the RNA-binding proteins CUGBP1 and MBNL1, misregulated in DM1. CUGBP1 activity is controlled by glycogen synthase kinase 3β (GSK3β), which is elevated in skeletal muscle of patients with DM1, and inhibitors of GSK3 were suggested as therapeutic molecules to correct CUGBP1 activity in DM1.</p>
</abstract>
<abstract>
<title>ABSTRACT</title>
<p>Myotonic dystrophy type 1 (DM1) is a multisystem neuromuscular disease without cure. One of the possible therapeutic approaches for DM1 is correction of the RNA-binding proteins CUGBP1 and MBNL1, misregulated in DM1. CUGBP1 activity is controlled by glycogen synthase kinase 3β (GSK3β), which is elevated in skeletal muscle of patients with DM1, and inhibitors of GSK3 were suggested as therapeutic molecules to correct CUGBP1 activity in DM1. Here, we describe that correction of GSK3β with a small-molecule inhibitor of GSK3, tideglusib (TG), not only normalizes the GSK3β-CUGBP1 pathway but also reduces the mutant <italic>DMPK</italic> mRNA in myoblasts from patients with adult DM1 and congenital DM1 (CDM1). Correction of GSK3β in a mouse model of DM1 (<italic>HSA<sup>LR</sup></italic> mice) with TG also reduces the levels of CUG-containing RNA, normalizing a number of CUGBP1- and MBNL1-regulated mRNA targets. We also found that the GSK3β-CUGBP1 pathway is abnormal in skeletal muscle and brain of DMSXL mice, expressing more than 1,000 CUG repeats, and that the correction of this pathway with TG increases postnatal survival and improves growth and neuromotor activity of DMSXL mice. These findings show that the inhibitors of GSK3, such as TG, may correct pathology in DM1 and CDM1 via several pathways.</p>
</abstract>
<kwd-group>
<title>KEYWORDS</title>
<kwd>congenital myotonic dystrophy</kwd>
<kwd>GSK3β</kwd>
<kwd>myotonic dystrophy type 1</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source>
<institution-wrap>
<institution>HHS | National Institutes of Health (NIH)</institution>
<institution-id>https://doi.org/10.13039/100000002</institution-id>
</institution-wrap>
</funding-source>
<award-id>AR064488</award-id>
<principal-award-recipient>
<name>
<surname>Timchenko</surname>
<given-names>Lubov</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award2">
<funding-source>
<institution-wrap>
<institution>HHS | National Institutes of Health (NIH)</institution>
<institution-id>https://doi.org/10.13039/100000002</institution-id>
</institution-wrap>
</funding-source>
<award-id>AR073379</award-id>
<principal-award-recipient>
<name>
<surname>Timchenko</surname>
<given-names>Lubov</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award3">
<funding-source>
<institution-wrap>
<institution>HHS | National Institutes of Health (NIH)</institution>
<institution-id>https://doi.org/10.13039/100000002</institution-id>
</institution-wrap>
</funding-source>
<award-id>CA159942</award-id>
<principal-award-recipient>
<name>
<surname>Timchenko</surname>
<given-names>Nikolai</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award4">
<funding-source>
<institution-wrap>
<institution>HHS | National Institutes of Health (NIH)</institution>
<institution-id>https://doi.org/10.13039/100000002</institution-id>
</institution-wrap>
</funding-source>
<award-id>DK102597</award-id>
<principal-award-recipient>
<name>
<surname>Timchenko</surname>
<given-names>Nikolai</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<counts>
<fig-count count="11"></fig-count>
<table-count count="2"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="38"></ref-count>
<page-count count="20"></page-count>
<word-count count="12557"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>November 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>